Medexus Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Medexus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $6.81. The average 1-year stock price forecast is 33.53% higher than the current stock price, while the lowest is $5.55 (+8.82%) and the highest is $8.00 (+56.86%).

Price Target: $6.81 (+33.53%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.55	$6.81	$6.50	$8.00
Change	+8.82%	+33.53%	+27.45%	+56.86%

Analyst Ratings

The average analyst rating for Medexus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	Jun '26
Strong Buy	6	5	5	5	5	5
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Martin PhD Bloom Burton	Bloom Burton	Buy Maintains $6.00	Buy	Maintains	$6.00	+17.65%	Jun 29, 2026

Financial Forecast

Revenue This Year

112.77M

from 99.33M

13.53%

from 99.33M

Revenue Next Year

138.76M

from 112.77M

23.05%

from 112.77M

EPS This Year

0.38

from -

EPS Next Year

0.66

from 0.38

73.57%

from 0.38

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	76.70M	108.10M	113.05M	108.33M	99.33M	112.77M
Revenue Growth	-3.72%	40.93%	4.59%	-4.18%	-8.31%	13.53%
Gross Profit	43.67M	65.77M	65.07M	63.51M	63.86M	69.51M
Gross Margin	56.94%	60.84%	57.56%	58.62%	64.29%	61.64%
Operating Income	-12.38M	8.49M	12.79M	11.92M	5.84M	12.27M
Net Income	-2.88M	1.22M	-214.00K	2.25M	-2.39M	9.50M
EPS	-	-	-	-	-	0.38
Forward PE	-	-	-	-	7.48	9.40
Free Cash Flow	-10.18M	-8.98M	8.47M	28.32M	-14.65M	10.82M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2027	2028	2029
High	118.8M
Avg	112.8M
Low	101.7M

Revenue Growth

Revenue Growth	2027	2028	2029
High	19.6%
Avg	13.5%
Low	2.4%

EPS Forecast

EPS	2027	2028	2029
High	0.38
Avg	0.38
Low	0.38

EPS Growth

EPS Growth	2027	2028	2029
High	101.3%
Avg	101.3%
Low	101.3%